453 related articles for article (PubMed ID: 14656321)
1. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
[TBL] [Abstract][Full Text] [Related]
2. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
[TBL] [Abstract][Full Text] [Related]
3. Relation of the [3H] gamma-hydroxybutyric acid (GHB) binding site to the gamma-aminobutyric acidB (GABAB) receptor in rat brain.
Snead OC
Biochem Pharmacol; 1996 Oct; 52(8):1235-43. PubMed ID: 8937431
[TBL] [Abstract][Full Text] [Related]
4. Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors.
Carter LP; Wu H; Chen W; Cruz CM; Lamb RJ; Koek W; Coop A; France CP
J Pharmacol Exp Ther; 2004 Jan; 308(1):182-8. PubMed ID: 14569056
[TBL] [Abstract][Full Text] [Related]
5. Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.
Koek W; Mercer SL; Coop A
Psychopharmacology (Berl); 2007 Jun; 192(3):407-14. PubMed ID: 17277933
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
Koek W; Carter LP; Wu H; Coop A; France CP
Behav Pharmacol; 2006 May; 17(3):239-47. PubMed ID: 16572002
[TBL] [Abstract][Full Text] [Related]
7. Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.
Mathivet P; Bernasconi R; De Barry J; Marescaux C; Bittiger H
Eur J Pharmacol; 1997 Feb; 321(1):67-75. PubMed ID: 9083788
[TBL] [Abstract][Full Text] [Related]
8. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
[TBL] [Abstract][Full Text] [Related]
9. Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists.
Carter LP; Wu H; Chen W; Matthews MM; Mehta AK; Hernandez RJ; Thomson JA; Ticku MK; Coop A; Koek W; France CP
J Pharmacol Exp Ther; 2005 Jun; 313(3):1314-23. PubMed ID: 15769868
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
[TBL] [Abstract][Full Text] [Related]
11. GHB receptor targets in the CNS: focus on high-affinity binding sites.
Bay T; Eghorn LF; Klein AB; Wellendorph P
Biochem Pharmacol; 2014 Jan; 87(2):220-8. PubMed ID: 24269284
[TBL] [Abstract][Full Text] [Related]
12. GABAB receptor-positive modulators: enhancement of GABAB receptor agonist effects in vivo.
Koek W; France CP; Cheng K; Rice KC
J Pharmacol Exp Ther; 2010 Oct; 335(1):163-71. PubMed ID: 20628000
[TBL] [Abstract][Full Text] [Related]
13. Effects of the GABAB receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and γ-hydroxybutyrate-discriminating pigeons.
Koek W; France CP; Cheng K; Rice KC
J Pharmacol Exp Ther; 2012 May; 341(2):369-76. PubMed ID: 22319197
[TBL] [Abstract][Full Text] [Related]
14. Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.
Castelli MP; Ferraro L; Mocci I; Carta F; Carai MA; Antonelli T; Tanganelli S; Cignarella G; Gessa GL
J Neurochem; 2003 Nov; 87(3):722-32. PubMed ID: 14535954
[TBL] [Abstract][Full Text] [Related]
15. Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors.
Bernasconi R; Lauber J; Marescaux C; Vergnes M; Martin P; Rubio V; Leonhardt T; Reymann N; Bittiger H
J Neural Transm Suppl; 1992; 35():155-77. PubMed ID: 1324978
[TBL] [Abstract][Full Text] [Related]
16. GABAB receptor-positive modulators: brain region-dependent effects.
Hensler JG; Advani T; Burke TF; Cheng K; Rice KC; Koek W
J Pharmacol Exp Ther; 2012 Jan; 340(1):19-26. PubMed ID: 21954301
[TBL] [Abstract][Full Text] [Related]
17. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.
Wu Y; Ali S; Ahmadian G; Liu CC; Wang YT; Gibson KM; Calver AR; Francis J; Pangalos MN; Carter Snead O
Neuropharmacology; 2004 Dec; 47(8):1146-56. PubMed ID: 15567424
[TBL] [Abstract][Full Text] [Related]
18. The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam.
Smith MA; Gergans SR; Lyle MA
Eur J Pharmacol; 2006 Dec; 552(1-3):83-9. PubMed ID: 17026996
[TBL] [Abstract][Full Text] [Related]
19. gamma-hydroxybutyrate increases a potassium current and decreases the H-current in hippocampal neurons via GABAB receptors.
Schweitzer P; Roberto M; Madamba SG; Siggins GR
J Pharmacol Exp Ther; 2004 Oct; 311(1):172-9. PubMed ID: 15152029
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose.
Koek W; Chen W; Mercer SL; Coop A; France CP
J Pharmacol Exp Ther; 2006 Apr; 317(1):409-17. PubMed ID: 16330491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
